These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 23110768)
1. Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist. Neutzsky-Wulff AV; Andreassen KV; Hjuler ST; Feigh M; Bay-Jensen AC; Zheng Q; Henriksen K; Karsdal MA J Transl Med; 2012 Oct; 10():214. PubMed ID: 23110768 [TBL] [Abstract][Full Text] [Related]
2. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
3. Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus. Meng LH; Huang Y; Zhou J; Liang XH; Xian J; Li L; Qin YF Chin Med J (Engl); 2017 Apr; 130(7):798-804. PubMed ID: 28345543 [TBL] [Abstract][Full Text] [Related]
4. [Effects of glycosylated hemoglobin and disease course on islet β-cell function in patients with type 2 diabetes]. Yinhui HE; Haiyan XU; Qi FU; Tao Y Nan Fang Yi Ke Da Xue Xue Bao; 2019 Sep; 39(9):1003-1008. PubMed ID: 31640950 [TBL] [Abstract][Full Text] [Related]
5. [Serum Uric Acid and Islet β-cell Function in Patients with Pre-diabetes and Type 2 Diabetes Mellitus]. Wu YT; He H; Wang X; Zhang M; An ZM; Huang HJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):69-73. PubMed ID: 29737093 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus. Dullaart RP; Annema W; de Boer JF; Tietge UJ Atherosclerosis; 2012 Jun; 222(2):567-73. PubMed ID: 22541874 [TBL] [Abstract][Full Text] [Related]
7. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function. McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335 [TBL] [Abstract][Full Text] [Related]
8. DPP-4 inhibitor treatment: β-cell response but not HbA Kozlovski P; Bhosekar V; Foley JE Vasc Health Risk Manag; 2017; 13():123-126. PubMed ID: 28408838 [TBL] [Abstract][Full Text] [Related]
9. Opposing effects of IL-1β/COX-2/PGE2 pathway loop on islets in type 2 diabetes mellitus. Wang G; Liang R; Liu T; Wang L; Zou J; Liu N; Liu Y; Cai X; Liu Y; Ding X; Zhang B; Wang Z; Wang S; Shen Z Endocr J; 2019 Aug; 66(8):691-699. PubMed ID: 31105125 [TBL] [Abstract][Full Text] [Related]
10. Islet-cell abnormalities in non-insulin-dependent diabetes mellitus. Raskin P Am J Med; 1985 Aug; 79(2B):2-5. PubMed ID: 3898829 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat. Cummings BP; Digitale EK; Stanhope KL; Graham JL; Baskin DG; Reed BJ; Sweet IR; Griffen SC; Havel PJ Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1782-93. PubMed ID: 18832086 [TBL] [Abstract][Full Text] [Related]
12. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
13. Ovarian hormone-induced beta-cell hypertrophy contributes to the homeostatic control of beta-cell mass in OLETF female rat, a model of Type II diabetes. Zhu M; Mizuno A; Kuwajima M; Ogino T; Murakami T; Noma Y; Sano T; Shima K Diabetologia; 1998 Jul; 41(7):799-805. PubMed ID: 9686921 [TBL] [Abstract][Full Text] [Related]
14. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits. Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk. Belongie KJ; Ferrannini E; Johnson K; Andrade-Gordon P; Hansen MK; Petrie JR PLoS One; 2017; 12(8):e0182932. PubMed ID: 28846711 [TBL] [Abstract][Full Text] [Related]
16. The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) model. Duong JK; de Winter W; Choy S; Plock N; Naik H; Krauwinkel W; Visser SA; Verhamme KM; Sturkenboom MC; Stricker BH; Danhof M Br J Clin Pharmacol; 2017 Mar; 83(3):487-497. PubMed ID: 27679422 [TBL] [Abstract][Full Text] [Related]
17. Effects of high-protein diet on glycemic control, insulin resistance and blood pressure in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Yu Z; Nan F; Wang LY; Jiang H; Chen W; Jiang Y Clin Nutr; 2020 Jun; 39(6):1724-1734. PubMed ID: 31466731 [TBL] [Abstract][Full Text] [Related]
18. 1,5-Anhydroglucitol × glycated hemoglobin A Su H; Ma X; Shen Y; He X; Ying L; Zhu W; Wang Y; Bao Y; Zhou J Acta Diabetol; 2020 Apr; 57(4):439-446. PubMed ID: 31728736 [TBL] [Abstract][Full Text] [Related]
19. Beta-cells in type 2 diabetes: a loss of function and mass. Maedler K; Donath MY Horm Res; 2004; 62 Suppl 3():67-73. PubMed ID: 15539803 [TBL] [Abstract][Full Text] [Related]
20. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]